Pediatric Rheumatology - Clinical and Therapeutic Aspects: Pediatric Rheumatology Systemic Lupus Erythematosus, Juvenile Dermatomyositis, Vasculitis and Other

Session Type: ACR Abstract Submissions
Tuesday, November 8, 2011: 9:00 AM-6:00 PM
Hall F2 - Poster Hall (McCormick Place West)
Papers:
The Childhood Myositis Assessment Scale (CMAS) Total Score in Healthy Children, Age 4-5 Years, is 46, Not 52. 
Rebecca Quinones1, Gabrielle Morgan1, Maria Amoruso1, Deli Wang2 and Lauren M. Pachman3, 1Children's Memorial Hospital, Chicago, IL, 2Northwestern University's Feinberg School of Medicine, Chicago, IL, 3Northwestern University Feinberg School of Medicine, Chicago, IL
The Pediatric Automated Neuropsychological Assessment Metrics Has Reproducibility and Criterion Validity in Childhood-Onset Lupus
Hermine Brunner1, Aimee Baker1, Adlin Cedeno2, Jennifer L. Huggins1, Anna Carmela P. Sagcal-Gironella3, Jun Ying4, Marisa Klein-Gitelman2 and Tresa Roebuck-Spencer5, 1Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Children's Memorial Hospital, Chicago, IL, 3Cincinnati Children's Hospital, Cincinnati, OH, 4University of Cincinnati, Cincinnati, OH, 5University of Oklahoma, Norman, OK
Therapeutic APPROACHES for the TREATMENT of NEW Onset and Flared Juvenile Systemic LUPUS Erythematosus with ACTIVE Renal DISEASE: AN International MULTICENTER PRINTO STUDY
Paivi Miettunen, Angela Pistorio, Angelo Ravelli, Sheila Oliveira, Maria Alessio, Ruben Cuttica, Dimitrina Mihaylova, Graciela Espada, Srdjan Pasic, Elisabetta Cortis, Seza Ozen, Oscar Porras, Flavio Sztajnbok, Alberto Martini and Nicolino Ruperto, IRCCS G. Gaslini, Pediatria II, PRINTO, Paediatric Rheumatology, Genova, Italy
Race, Ethnicity and Gender Affect the Severity of Renal Outcomes in Patients with Pediatric Systemic Lupus Erythematosus: An Analysis of the CARRAnet Data At Baseline Visit
Ornella J. Rullo1, Deborah K. McCurdy1, Ora Yadin1, Alice DC Hoftman1, Jennifer M.P. Woo1, Emily von Scheven2 and CARRAnet Investigators3, 1Mattel Children's Hospital, University of California, Los Angeles, Los Angeles, CA, 2UC San Francisco, San Francisco, CA, 3Durham
Behavior, Executive and Perceived Neuropsychological Functioning with Childhood-Onset Systemic Lupus Erythematosus – Results of a Best-Friend Controlled Study
Adlin Cedeno1, Aimee Baker2, Marisa Klein-Gitelman1, Anna Carmela P. Sagcal-Gironella2, April German2, Cynthia Scharf2, Jun Ying3, Hermine Brunner2, Dean Beebe2 and Frank Zelko1, 1Children's Memorial Hospital, Chicago, IL, 2Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 3University of Cincinnati, Cincinnati, OH
The PRINTO Provisional Definition of REMISSION In Juvenile Dermatomyositis
Dragana Lazarevic1, Angela Pistorio1, Paivi Miettunen1, Angelo Ravelli1, Clara Malattia1, Clarissa Pilkington1, Nico Wulffraat1, Stella Maris Garay2, Michael Hofer1, Pierre Quartier1, Pavla Dolezalova2, Inmaculada Calvo Penades1, Virginia P.L. Ferriani1, Gerd Ganser3, Ozgur Kasapcopur1, Jose Antonio Melo-Gomes1, Malgorzata Wierzbowska1, Alberto Martini1 and Nicolino Ruperto1, 1IRCCS G. Gaslini, Pediatria II, PRINTO, Paediatric Rheumatology, Genova, Italy, 2Paediatric Rheumatology International Trials Organization, Genoa, Italy, 3Sankt Josef Stift, Sendenhorst, Germany
Determination of Pediatric Doses of Colchicine for Familial Mediterranean Fever on the Basis of Population Pharmacokinetics
Yackov Berkun1, Eldad Ben-Chetrit1, Suman Wason2, Robert Faulkner2 and Stephen Levenstein3, 1Hadassah Hebrew University Medical Center, Jerusalem, Israel, 2URL Pharma, Philadelphia, PA, 3GCP Clinical Studies Ltd., Rosh Ha’Ayin, Israel
Performance of the Systemic Lupus Erythematosus Responder Index in Juvenile Systemic Lupus Erythematosus
Rina Mina1, Marisa Klein-Gitelman2, Shannen L. Nelson3, B. Anne Eberhard4, Gloria C. Higgins5, Nora G. Singer6, Deborah M. Levy7, Karen Onel8, Judyann C. Olson9, Joshua D. Pendl10, Aimee Baker10, Lisa F. Imundo11, Lori B. Tucker12, Laura E. Schanberg13, Marilynn G. Punaro14, Kathleen M. O'Neil15, Nicolino Ruperto16, Daniel J. Lovell10 and Hermine Brunner10, 1Cincinnati Children's Med Ctr, Cincinnati, OH, 2Children's Memorial Hospital, Chicago, IL, 3Cincinnati Children's Hospital, Cincinnati, OH, 4Cohen Children's Hospital Medical Center, New Hyde Park, NY, 5Nationwide Childrens Hosp, Columbus, OH, 6MetroHealth Medical Center, Cleveland, OH, 7The Hospital for Sick Children, Toronto, ON, 8University of Chicago, Chicago, IL, 9Medical College of Wisconsin, Milwaukee, WI, 10Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 11Childrens Hospital of New York, Columbia University Medical Center, New York, NY, 12BC Childrens Hospital, Vancouver, BC, 13Duke University Medical Center, Durham, NC, 14Texas Scottish Rite Hospital, Dallas, TX, 15Okla Univ Health Science Ctr, Oklahoma City, OK, 16PRINTO-IRCCS, Genova, Italy
A Secondary Analysis of the Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) Study Shows That Atorvastatin Therapy Reduces Progression of Carotid Intima Medial Thickening in Pubertal SLE Patients with Higher C Reactive Protein
Stacy P. Ardoin1, Laura E. Schanberg2, Christy I. Sandborg3, Huiman Barnhart4, Eric Yow4, Greg Evans5, Kelly Mieszkalski2, Norman T. Ilowite6, Emily von Scheven7, B. Anne Eberhard8, Lisa F. Imundo9, Deborah M. Levy10, Yuki Kimura11, Earl D. Silverman12, Suzanne L. Bowyer13, Marilynn G. Punaro14, Nora G. Singer15, David D. Sherry16, Deborah K. McCurdy17, Marisa Klein-Gitelman18, Carol A. Wallace19, Richard M. Silver20, Linda Wagner-Weiner21, Gloria Higgins22 and Hermine Brunner23, 1Ohio State University, Columbus, OH, 2Duke University Medical Center, Durham, NC, 3Stanford University, Palo Alto, CA, 4Duke Clinical Research Institute, Durham, NC, 5Winston-Salem, NC, 6Children's Hospital Montefiore, Bronx, NY, 7UC San Francisco, San Francisco, CA, 8Cohen Children's Hospital Medical Center, New Hyde Park, NY, 9Childrens Hospital of New York, Columbia University Medical Center, New York, NY, 10The Hospital for Sick Children, Toronto, ON, 11Pediatrics, Hackensack, NJ, 12Hospital for Sick Children, Toronto, ON, 13James Whitcomb Riley Hospital, Indianapolis, IN, 14Texas Scottish Rite Hospital, Dallas, TX, 15Director, Division of Rheumatology, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH, 16Children's Hospital of Philadelphia, Philadelphia, PA, 17Mattel Children's Hospital, University of California, Los Angeles, Los Angeles, CA, 18Children's Memorial Hospital, Chicago, IL, 19Childrens Hosp & Regional Med, Seattle, WA, 20MUSC, Charleston, SC, 21University of Chicago Hospital, Chicago, IL, 22NATIONWIDE CHILDRENS HOSPITAL, Columbus, OH, 23Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Ovarian Reserve in Juvenile Systemic Lupus Erythematosus Patients without Amenorrhea
Nadia E. Aikawa1, Adriana M. Sallum2, Rosa M.R. Pereira3, Eloisa Bonfa4, Lisa Suzuki5, Vilma S.T. Viana1 and Clovis A. Silva6, 1Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 2Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo-SP, Brazil, 3Disciplina de Reumatologia da FMUSP, Sao Paulo, Brazil, 4University of Sao Paulo, Sao Paulo, Brazil, 5Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil, 6Instituto da Criança, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil
Maternal Autoimmunity and Neonatal Brain Abnormalities: Cerebral Dysmaturation, Diencephalon Abnormalities, and Lenticulostriate Vasculopathy
Jennifer D. Frankovich1, Patrick D. Barnes1, Christy I. Sandborg1 and Eliza F. Chakravarty2, 1Stanford University, Palo Alto, CA, 2Oklahoma Medical Research Foundation, Oklahoma City, OK
Long-Term Methotrexate Efficacy in Juvenile Localized Scleroderma
Francesco Zulian1, Cristina Vallongo1, Fabio Vittadello1, Annalisa Patrizi2, Maria Alessio3, Anna Belloni Fortina1, Silvana Martino4 and Giorgia Martini1, 1University of Padua, Padova, Italy, 2University of Bologna, Bologna, Italy, 3University of Naples Federico II, Napoli, Italy, 4University of Turin, Italy
Diagnostic Evaluation and Medication Usage in a Cohort of Subjects with Juvenile Dermatomyositis Recruited within the First 11 Months of the Children's Arthritis and Rheumatology Research Alliance Registry
Angela B. Robinson1, Mark F. Hoeltzel2, ML Becker2, Dawn M. Wahezi3, Adam M. Huber4, Brian M. Feldman5, Ann M. Reed6 and Juvenile Myositis CARRA Subgroup for CARRAnet Investigators7, 1Rainbow Babies and Childrens Hospital, Cleveland, OH, 2Children's Mercy Hospital, Kansas City, MO, 3Children's Hospital Montefiore, Bronx, NY, 4Dalhousie University, Halifax, NS, 5The Hospital for Sick Children, Toronto, ON, 6Mayo Clinic, Rochester, MN, 7Varies by Investigator
Influenza A H1N1/2009 Vaccine in Juvenile Dermatomyositis: Reduced Response in Patients Under Immunosuppressive Agents
Vanessa R. Guissa1, Nadia E. Aikawa2, Adriana M. Sallum1, Lucia M.A. Campos3, Rosa M.R. Pereira4, Eloisa Bonfa5 and Clovis A. Silva1, 1Faculdade de Medicina da Universidade de São Paulo, São Paulo-SP, Brazil, 2Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 3Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil, 4Disciplina de Reumatologia da FMUSP, Sao Paulo, Brazil, 5University of Sao Paulo, São Paulo, Brazil
Creation of A COHORT of French PATIENTS with CHRONIC RECURRENT Multifocal OSTEITIS : PRELIMINARY RESULTS
Julien Wipff1, M.-A. Dumitrescu2, Mathie Lorrot3, Albert Faye2, S. lacassagne-Compeyrot4, B. Bader Meunier4, R. Mouy4, Carine H. Wouters5, Marine Desjonqueres6, S. Jean7, V. Despert7, A. Duquesne6, I. Lemelle8, P. Pillet9, M. Grall-Lerosey10, Pierre Quartier11 and Chantal Job-Deslandre12, 1Paris descartes Universityn Rheumatology A, Cochin Hospital, Paris, France, 2Paris, France, 3Paediatry, Robert Debré hospital, Paris, France, 4University Paris Descartes, Paediatry, Necker hospital, Paris, France, 5Paediatric Rheumatology Internationsl Trials Organization, Leuven, Belgium, 6Hopital Femme Mere Enfant, Groupement Hospitalier Est, Lyon, France, 7Paediatry, CHU, Rennes, France, 8Paediatry, CHU, Nancy, France, 9Paediatry, CHU, Bordeaux, France, 10Paediatry, CHU, Rouen, France, 11Hôpital Necker-Enfants Malades, Paris, France, 12Hopital Cochin, Paris Cedex 14, France
Recurrent Arthritis As the Sole Presenting Manifestation of Hereditary Autoinflammatory Syndromes
Giulia Vigo1, Giorgia Martini1, Fabio Vittadello1, Isabella Ceccherini2, Laura Obici3 and Francesco Zulian1, 1University of Padua, Padova, Italy, 2G. Gaslini Institute, Genova, Italy, 3IRCCS Policlinico S. Matteo, Pavia, Italy
Description of the Localized Scleroderma Subgroup of the CARRAnet Registry
Eveline Y. Wu, Duke Univ Med Ctr, Durham, NC, Egla C. Rabinovich, Duke University Medical Center, Durham, NC, Kathryn S. Torok, Univ of Pittsburgh Med Ctr, Pittsburgh, PA, Suzanne C. Li, Hackensack Univ Med Ctr, Hackensack, NJ, Robert C. Fuhlbrigge, Childrens Hospital, Boston, MA and CARRANet Investigators, Stanford
Parents’ Attitudes towards Research and Research Study Participation in Pediatric Rheumatology (PR)
America Uribe1, Lori B. Tucker2, Louise Masse1, Jaime Guzman1 and David A. Cabral3, 1BC Children's Hospital, Vancouver, BC, 2BC Childrens Hospital, Vancouver, BC, 3University of British Columbia, Vancouver, BC
Long-Term Mental Health Outcomes in Pediatric-Onset Systemic Lupus Erythematosus
Erica F. Lawson1, Aimee O. Hersh2, Laura J. Julian1, Laura Trupin3, Emily von Scheven3, Patricia P. Katz4 and Edward Yelin1, 1University of California San Francisco, San Francisco, CA, 2University of Utah, Salt Lake City, UT, 3UC San Francisco, San Francisco, CA, 4Univercity of California San Francisco, San Francisco, CA
Quality of Life and Psychosocial Aspects Among School Adolescents with Diffuse Chronic Musculoskeletal Pain in Brazil
AK Nascif1, V. Valim1, M. Dorio2, JR Gomes1, AFA Pereira1, E. Zandonade1 and Claudio Len3, 1Universidade Federal do Espírito Santo, Vitória, Brazil, 2Vitória, Brazil, 3Universidade Federal de São Paulo / UNIFESP, Sao Paulo, Brazil
Race Is a Risk Factor for Calcinosis in Patients with Juvenile Dermatomyositis: Early Observations From the Childhood Arthritis and Rheumatology Research Alliance Registry (CARRAnet)
Mark F. Hoeltzel1, ML Becker1, Angela B. Robinson2, Adam M. Huber3, Brian M. Feldman4, Ann M. Reed5 and Juvenile Myositis CARRA Subgroup for CARRAnet Investigators6, 1Children's Mercy Hospital, Kansas City, MO, 2Rainbow Babies and Childrens Hospital, Cleveland, OH, 3Dalhousie University, Halifax, NS, 4The Hospital for Sick Children, Toronto, ON, 5Mayo Clinic, Rochester, MN, 6Various
Anakinra for the Treatment of Hyper-IgD with Periodic Fever Syndrome in Children
Donald P. Goldsmith1, Karyl S. Barron2, Amanda K. Ombrello3, Robert Lembo3, Deborah Stone3, Anne Jones4, Dawn C. Chapelle Neal5 and Daniel L. Kastner6, 1Drexel University College of Medicine/St Christophers Hosp for Child, Philadelphia, PA, 2NIAID-NIH, Bethesda, MD, 3National Institutes of Health, Bethesda, MD, 4NIH-NIAMS, Bethesda, MD, 5NIAMS, Bethesda, MD, 6National Human Genome Research Institute, National Institutes of Health, Bethesda, MD
Mycophenolate Mofetil in Children with Lupus: Clinical Findings in Favour of Therapeutic Drug Monitoring
Brigitte Bader-Meunier1, Camille Jurado2, Bruno Ranchin3, Stéphane Decramer4, Michel Fischbach5, Etienne Berard6 and Franck Saint Marcoux2, 1Hôpital Necker, Paris, France, 2INSERM UMR –S850, Limoges, France, 3Hôpital Femme-Mère-Enfant, Lyon, France, 4hôpital Purpan, Toulouse, France, 5Hôpital Hautepierre, Strasbourg, France, 6Hôpital Lenval, Nice, France
Autoantibody Testing for Children on Biologic Therapies for Rheumatological Conditions: Results of Audit
Julie Duncan1, Jill Heath1, Eileen M. Baildam2, Gavin Cleary1, Michael W. Beresford1 and Liza J. McCann1, 1Alder Hey Children's NHS Foundation Trust, Liverpool, United Kingdom, 2Paediatric Rheumatology International Trials Organization, Genoa, Italy
Effects of Pediatric-Onset Systemic Lupus Erythematosus on Final Linear Height: Evidence From a Large Observational Cohort
Laura Trupin1, Aimee O. Hersh2, Jinoos Yazdany3, Erica F. Lawson1 and Emily von Scheven1, 1UC San Francisco, San Francisco, CA, 2University of Utah, Salt Lake City, UT, 3University of California San Francisco, San Francisco, CA
“Living Well” Chronic Disease Self-Management Program for Adolescents with Rheumatic Disease 
Sheetal Vora, Medical College of Wisconsin, Milwaukee, WI and Elizabeth L. Roth-Wojcicki, Medical College of WI, Wauwatosa, WI
Ethnic Differences of Early Disease Severity in Pediatric Systemic Lupus Erythematosus At An Urban Tertiary Care Center
Jennifer M.P. Woo1, Peony Liu2, Miriam F. Parsa1, Gil Amarilyo1, Alice DC Hoftman2, Deborah K. McCurdy2 and Ornella J. Rullo2, 1University of California, Los Angeles, Los Angeles, CA, 2Mattel Children's Hospital, University of California, Los Angeles, Los Angeles, CA
Clinical Characteristics of Children with Juvenile Dermatomyositis Recruited within the First 11 Months of the Children’s Arthritis and Rheumatology Research Alliance Registry (CARRAnet)
Mark F. Hoeltzel1, ML Becker1, Angela B. Robinson2, Adam M. Huber3, Brian M. Feldman4, Ann M. Reed5 and Juvenile Myositis CARRA Subgroup for CARRAnet Investigators6, 1Children's Mercy Hospital, Kansas City, MO, 2Rainbow Babies and Childrens Hospital, Cleveland, OH, 3Dalhousie University, Halifax, NS, 4The Hospital for Sick Children, Toronto, ON, 5Mayo Clinic, Rochester, MN, 6Various
Outcome of Babies Born to Mothers with Systemic Auto-Immune Diseases
Noemie Abisror1, Arsene Mekinian1, Eric Lachassinne2, Pascale nicaise-Roland3, Jerome Stirnemann4, Loic de Pontual*2, Lionel Carbillon5 and Olivier Fain4, 1Jean Verdier Hospital, Bondy, France, 2Service de néonatologie et pédiatrie, Université Paris 13, AP-HP, Hôpital Jean Verdier, 93140, Bondy, France., Bondy, France, 3Unité Fonctionnelles d'Immunologie « Autoimmunité et Hypersensibilités », AP-HP, Hôpital Bichat-Claude Bernard, Paris, Paris, France, 4Service de médecine interne, Université Paris 13, AP-HP, Hôpital Jean Verdier, 93140, Bondy, France., Bondy, France, 5Service de gynécologie-obstétrique, Université Paris 13, AP-HP, Hôpital Jean Verdier, 93140, Bondy, France., Bondy, France
Accrual Damage Assessment In Juvenile-Onset Systemic Lupus Erythematosus
Juan G. Ovalles, Julia Martínez-Barrio, Francisco J. López-Longo, Inmaculada de la Torre, Lina Martínez-Estupiñán, Juan C. Nieto and Luis Carreño, Gregorio Marañón Hospital, Madrid, Spain
Low Vitamin D in Juvenile Onset Systemic Lupus Erythematosus: Association with Disease Activity and Low Bone Mineral Density
Luciana P.C. Seguro1, Caio B. Casella1, Liliam Takayama2, Eloisa Bonfa3 and Rosa M.R. Pereira4, 1University of Sao Paulo, Sao Paulo, Brazil, 2Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 3University of Sao Paulo, São Paulo, Brazil, 4Disciplina de Reumatologia da FMUSP, Sao Paulo, Brazil
Use of Urinary Metabolites to Distinguish Proliferative From Membranous Lupus Nephritis
Shannen L. Nelson1, Rina Mina2, Lindsey Romick-Rosendale3, Hermine Brunner4, Michael Bennett2, Joshua D. Pendl4, Michelle Petri5, Adnan Kiani5, Prasad Devarajan2 and Michael Kennedy6, 1Cincinnati Children's Hospital, Cincinnati, OH, 2Cincinnati Children's Med Ctr, Cincinnati, OH, 3Miami University, Ohio, Oxford, OH, 4Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 5Johns Hopkins University School of Medicine, Baltimore, MD, 6Miami University, Oxford, Oxford, OH
Effectiveness of Anti-Tumor Necrosis Factor-α Agents in the Treatment of Refractory Juvenile Dermatomyositis
E.L. Boulter1, L. Beard2, Clive Ryder3, Clarissa Pilkington1 and Juvenile Dermatomyositis Research Group4, 1Great Ormond Street Hospital, London, United Kingdom, 2UCL Institute of Child Health, London, United Kingdom, 3Birmingham Children's Hospital NHS Foundation Trust, Birmingham, United Kingdom, 4London, United Kingdom
Treatment Delay in Kawasaki Disease – the Role of Non-Traditional Risk Factors
Nadia Luca1, Joyce C. Y. Ching1, Cedric Manlhiot2, Brian W. McCrindle2 and Rae SM Yeung1, 1Hospital for Sick Children, Toronto, ON, 2The Hospital for Sick Children, Toronto, ON
Health Care Transition Improvement Utilizing Learning Collaborative and the New Six Core Transition Elements
Patience H. White1, Peggy McManus2, Jeanne McAllister3 and Carl Cooley3, 1Arthritis Foundation, Washington, DC, 2National Alliance to Advance Adolescent Health, Washington, DC, 3Center for Medical Home Improvement, Concord, NH
Mycophenolate Mofetil (MMF) Versus Azathioprine As Maintenance Therapy Combined with Monthly Intravenous Cyclophsophamide (IVCY) in Juvenile Lupus Nephritis
Toshitaka Kizawa, Tomoyuki Imagawa, Tomo Nozawa, Masako Kikuchi, Tomonori Harada, Takako Miyamae and Shumpei Yokota, Yokohama City University, Yokohama, Japan
Inpatient Treatment Variation of Children Hospitalized with Complex Regional Pain Syndrome
Cara Hoffart1, Pamela Weiss2, Andrew J. Klink3, David D. Sherry3 and Chris Feudtner4, 1The Childrens Hospital of Philadelphia, Philadelphia, PA, 2The Children's Hospital of Philadelphia, Philadelphia, PA, 3Children's Hospital of Philadelphia, Philadelphia, PA, 4Division of General Pediatrics, Children's Hospital of Philadelphia; University of Pennsylvania Center for Clinical Epidemiology and Biostatistics, Philadelphia, PA
Children with Ehlers-Danlos Syndrome and Airway Dysfunction
Sanjay J. Khiani1, Sara Lowe1, Michael Zacharisen1 and Sheetal Vora2, 1Medical College of Wisconsin and the Children's Research Institute, Wauwatosa, WI, 2Medical College of Wisconsin, Milwaukee, WI
Cytomegalovirus in Pediatric Systemic Lupus Erythematosus: Screening and Therapeutic Implications
Evelyn V. Rozenblyum, Deborah M. Levy, Elizabeth Harvey, Diane Hebert and Earl D. Silverman, Hospital for Sick Children, Toronto, ON
Alveolar Hemorrhage: Distinct Clinical Profile in Adult and Juvenile Systemic Lupus Erythematosus Patients
Daniel B. Araujo1, Eduardo F. Borba Neto1, Clovis A. Silva1, Lucia M.A. Campos1, Rosa M.R. Pereira2, Eloisa Bonfa1 and Samuel K. Shinjo1, 1Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil, 2Disciplina de Reumatologia da FMUSP, Sao Paulo, Brazil
CD146+ Endothelial Progenitor Cell Number Increases Following 36 Months of Atorvastatin Therapy in Children and Adolescents with SLE: The Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) Cohort
Stacy P. Ardoin1, Thomas Povsic2, Laura E. Schanberg3, Christy I. Sandborg4, Huiman Barnhart5, Eric Yow5, Greg Evans6, Kelly L. Mieszkalski3, Norman T. Ilowite7, Emily von Scheven8, B. Anne Eberhard9, Lisa F. Imundo10, Yuki Kimura11, Earl D. Silverman12, Suzanne L. Bowyer13, Marilynn G. Punaro14, Nora G. Singer15, David D. Sherry16, Deborah K. McCurdy17, Marisa Klein-Gitelman18, Carol Wallace19, Richard M. Silver20, Linda Wagner-Weiner21, Gloria C. Higgins22 and Hermine Brunner23, 1Ohio State University, Columbus, OH, 2Duke University, Durham, NC, 3Duke University Medical Center, Durham, NC, 4Stanford University, Palo Alto, CA, 5Duke Clinical Research Institute, Durham, NC, 6Winston-Salem, NC, 7Children's Hospital Montefiore, Bronx, NY, 8UC San Francisco, San Francisco, CA, 9Cohen Children's Hospital Medical Center, New Hyde Park, NY, 10Childrens Hospital of New York, Columbia University Medical Center, New York, NY, 11Pediatrics, Hackensack, NJ, 12Hospital for Sick Children, Toronto, ON, 13James Whitcomb Riley Hospital, Indianapolis, IN, 14Texas Scottish Rite Hospital, Dallas, TX, 15Director, Division of Rheumatology, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH, 16Children's Hospital of Philadelphia, Philadelphia, PA, 17Mattel Children's Hospital, University of California, Los Angeles, Los Angeles, CA, 18Children's Memorial Hospital, Chicago, IL, 19Childrens Hosp & Regional Med, Seattle, WA, 20MUSC, Charleston, SC, 21University of Chicago Hospital, Chicago, IL, 22Nationwide Childrens Hosp, Columbus, OH, 23Cincinnati Children's Hospital Medical Center, Cincinnati, OH
See more of: ACR Abstract Submissions

To see other sessions for this day, use the date buttons to the left.